Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Announcement Summary | |||
only | Entity name | ||
NEUROTECH INTERNATIONAL LIMITED | |||
Date of this announcement | |||
Thursday March 10, 2022 | |||
The +securities the subject of this notification are: | |||
Other | |||
use | Total number of +securities to be issued/transferred | ||
ASX +security | |||
code | Security description | ||
New class - code | Unlisted Options ($0.08, 10 March 2024) | ||
to be confirmed | |||
personalFor | New class - code | Unlisted Options ($0.12, 10 March 2024) | |
to be confirmed | |||
New class - code | Unlisted Options ($0.16,10 March 2024) | ||
to be confirmed | |||
Refer to next page for full details of the announcement |
Total number of +securities to be
issued/transferred Issue date
5,000,000 10/03/2022
5,000,000 10/03/2022
5,000,000 10/03/2022
Notification of Issue, Conversion or Payment up of Unquoted | 1 / 12 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of entity
NEUROTECH INTERNATIONAL LIMITED
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 | Registered number type | Registration number |
ABN | 73610205402 | |
1.3 | ASX issuer code | |
NTI | ||
1.4 The announcement is | ||
New announcement | ||
1.5 | Date of this announcement |
10/3/2022
Notification of Issue, Conversion or Payment up of Unquoted | 2 / 12 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 2 - Issue details
For personal use only
2.1 The +securities the subject of this notification are: Other
Please specify
The securities in the Appendix 3B dated 3 March 2022 have not been provided with a security code
2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:
does not have an existing ASX security code ("new class")
Notification of Issue, Conversion or Payment up of Unquoted | 3 / 12 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX in an Appendix 3B
only | New +securities | |||
ASX +security code | +Security description | |||
New class - code to be confirmed | Unlisted Options ($0.08, 10 March 2024) | |||
+Security type | ISIN code | |||
Options | ||||
use | Date the +securities the subject of this notification were issued | |||
10/3/2022 | ||||
Will all the +securities issued in this class rank equally in all respects from their issue date? | ||||
personal | Yes | |||
Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under | ||||
listing rule 6.1? | ||||
No | ||||
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being | ||||
issued. | ||||
Subject to vesting conditions, the Options will be exercisable at $0.08 and expire two years from their date of issue. The | ||||
Options will vest 12 months after the commencement date of Dr Andrews as CEO, subject to Dr Andrews remaining | ||||
continually employed by the Company on this date. | ||||
Refer to the ASX release dated 3 March 2022 for further information. | ||||
Options Details | ||||
+Security currency | Exercise price | Expiry date | ||
For | AUD - Australian Dollar | AUD 0.08000000 | 10/3/2024 | |
Details of the existing class of +security that will be issued upon exercise or conversion of this new class of | ||||
company option | ||||
Other | ||||
Description | ||||
Unlisted Options ($0.08, 10 March 2024) | ||||
Any other information the entity wishes to provide about the +securities the subject of this notification
N/A
Notification of Issue, Conversion or Payment up of Unquoted | 4 / 12 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Please provide any further information needed to understand the circumstances in which you are notifying the issue of these +securities to ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B
The securities were proposed to be issued in the Appendix 3B dated 3 March 2022 however the securities have not been provided with a security class code to date.
only | |||||
Issue details | |||||
Number of +securities | |||||
5,000,000 | |||||
use | Were the +securities issued for a cash consideration? | ||||
No | |||||
Please describe the consideration being provided for the +securities | |||||
The Company has issued 5,000,000 options to CEO, Alexandra Andrews, as the first tranche of the equity based | |||||
component to her remuneration package. | |||||
Purpose of the issue | |||||
personal | Other | ||||
Additional Details | |||||
The securities form the equity based component to the CEO's remuneration package. | |||||
New +securities | |||||
ASX +security code | +Security description | ||||
New class - code to be confirmed | Unlisted Options ($0.12, 10 March 2024) | ||||
+Security type | ISIN code | ||||
Options | |||||
Date the +securities the subject of this notification were issued | |||||
For | 10/3/2022 | ||||
Will all the +securities issued in this class rank equally in all respects from their issue date?
Yes
Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1?
No
Notification of Issue, Conversion or Payment up of Unquoted | 5 / 12 |
This is an excerpt of the original content. To continue reading it, access the original document here.